Boston Scientific Stock Forecast, Price & News

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 5 hold ratings, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Boston Scientific stock.
View analyst ratings for Boston Scientific or view top-rated stocks.

Wall Street analysts have given Boston Scientific a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Boston Scientific wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Boston Scientific.

Boston Scientific Co. (NYSE:BSX) posted its quarterly earnings results on Tuesday, April, 27th. The medical equipment provider reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.06. The medical equipment provider earned $2.75 billion during the quarter, compared to analysts' expectations of $2.62 billion. Boston Scientific had a trailing twelve-month return on equity of 9.80% and a net margin of 1.69%. The company's revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.28 EPS.
View Boston Scientific's earnings history.

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BSX stock has increased by 26.3% and is now trading at $42.75.
View which stocks have been most impacted by COVID-19.

Boston Scientific updated its FY 2021 earnings guidance on Wednesday, May, 5th. The company provided earnings per share (EPS) guidance of 1.530-1.600 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.540. The company issued revenue guidance of $11.50 billion-$11.80 billion, compared to the consensus revenue estimate of $11.43 billion.

19 brokerages have issued twelve-month price targets for Boston Scientific's stock. Their forecasts range from $43.00 to $52.00. On average, they expect Boston Scientific's share price to reach $46.95 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price.
View analysts' price targets for Boston Scientific or view top-rated stocks among Wall Street analysts.

947 employees have rated Boston Scientific CEO Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among Boston Scientific's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Teleflex (TFX), Insulet (PODD), STERIS (STE), Hologic (HOLX) and Abiomed (ABMD).
View all of BSX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), The Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and salesforce.com (CRM).

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.20%), Massachusetts Financial Services Co. MA (5.82%), Janus Henderson Group PLC (3.59%), Primecap Management Co. CA (2.89%), Bollard Group LLC (2.21%) and Artisan Partners Limited Partnership (1.63%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, Scott Olson, Wendy Carruthers and Williamson Scott.
View institutional ownership trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Price T Rowe Associates Inc. MD, Prudential Financial Inc., BlackRock Inc., Morgan Stanley, Assenagon Asset Management S.A., Caisse DE Depot ET Placement DU Quebec, and Jennison Associates LLC. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Edward F Mackey, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, Scott Olson, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific or view top insider-selling stocks.

BSX stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Parnassus Investments CA, Holocene Advisors LP, Janus Henderson Group PLC, Deerfield Management Company L.P. Series C, Neuberger Berman Group LLC, Artisan Partners Limited Partnership, and Primecap Management Co. CA.
View insider buying and selling activity for Boston Scientific or or view top insider-buying stocks.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BSX stock can currently be purchased for approximately $42.75.

Boston Scientific has a market capitalization of $60.74 billion and generates $9.91 billion in revenue each year. The medical equipment provider earns $-82,000,000.00 in net income (profit) each year or $0.96 on an earnings per share basis.

Boston Scientific employs 38,000 workers across the globe.

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.

Boston Scientific was founded in 1979.

The official website for Boston Scientific is www.bostonscientific.com.

Boston Scientific is headquartered at 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 683-4000 or via email at [email protected]